Literature DB >> 19470910

Revisiting the prognostic value of regulatory T cells in patients with cancer.

Cecile Badoual, Stephane Hans, Wolf H Fridman, Daniel Brasnu, Susan Erdman, Eric Tartour.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19470910     DOI： 10.1200/JCO.2009.23.0680

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

Review 1.  The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications.

Authors:  Panagiota Economopoulou; Christos Perisanidis; Evaggelos I Giotakis; Amanda Psyrri
Journal:  Ann Transl Med       Date:  2016-05

2.  Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander?

Authors:  Giovanni D'Arena; Vittorio Simeon; Fiorella D'Auria; Teodora Statuto; Paola Di Sanzo; Laura De Martino; Aurelio Marandino; Michele Sangiorgio; Pellegrino Musto; Vincenzo De Feo
Journal:  Am J Blood Res       Date:  2013-01-17

Review 3.  Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.

Authors:  Noelia Purroy; Catherine J Wu
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 4.  Checkpoint immunotherapy in head and neck cancers.

Authors:  Paul Zolkind; Ravindra Uppaluri
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

Review 5.  Cancer inflammation and regulatory T cells.

Authors:  Susan E Erdman; Theofilos Poutahidis
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

6.  The role of regulatory T cells in cancer.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

7.  The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma.

Authors:  Aashiyana F Koreishi; Adam J Saenz; Dan O Persky; Hayan Cui; Allison Moskowitz; Craig H Moskowitz; Julie Teruya-Feldstein
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-05

Review 8.  The prognostic impact of anti-cancer immune response: a novel classification of cancer patients.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Wolf-Herman Fridman; Jérôme Galon
Journal:  Semin Immunopathol       Date:  2011-04-05       Impact factor: 9.623

9.  Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

Authors:  Katy Milne; Martin Köbel; Steven E Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

10.  The tumor microenvironment: a pitch for multiple players.

Authors:  Giovanna Schiavoni; Lucia Gabriele; Fabrizio Mattei
Journal:  Front Oncol       Date:  2013-04-17       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.